Aktana Revenue and Competitors

Location

$99.2M

Total Funding

AI

Industry

Estimated Revenue & Valuation

  • Aktana's estimated annual revenue is currently $40.2M per year.(i)
  • Aktana received $17.5M in venture funding in June 2016.
  • Aktana's estimated revenue per employee is $150,500
  • Aktana's total funding is $99.2M.

Employee Data

  • Aktana has 267 Employees.(i)
  • Aktana grew their employee count by -4% last year.

Aktana's People

NameTitleEmail/Phone
1
Chief ArchitectReveal Email/Phone
2
CEOReveal Email/Phone
3
CEOReveal Email/Phone
4
VP Sales - North AmericaReveal Email/Phone
5
VP Professional Services, Americas & EMEAReveal Email/Phone
6
SVP Global SalesReveal Email/Phone
7
VP, PeopleReveal Email/Phone
8
VP MarketingReveal Email/Phone
9
SVP, Business DevelopmentReveal Email/Phone
10
VP, FinanceReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$27M17526%N/AN/A
#2
$0.2M3-70%N/AN/A
#3
$4.6M41-20%N/AN/A
#4
$7.3M60-32%$11.6MN/A
#5
$3.6M340%$11.4MN/A
#6
$5.2M46-15%N/AN/A
#7
$0.8M10N/AN/AN/A
#8
$14.1M101-13%$21.5MN/A
#9
$1.4M17N/AN/AN/A
#10
$4.4M3911%N/AN/A
Add Company

What Is Aktana?

Aktana is the pioneer in decision support for global life sciences sales and marketing teams. The company's data-fueled suggestions and insights are delivered within a sales professional's existing CRM workflow, serving as a critical ally in data leverage and better decision-making. Aktana serves the entire organization by helping to coordinate multichannel marketing initiatives and facilitate learning about which program elements are most successful for which customers. Nearly half of the world's top 20 pharmaceutical companies rely on Aktana to drive more insightful marketing and sales programs. Aktana is headquartered in San Francisco, with offices in New York, Philadelphia, London, Tokyo, Osaka, and Shanghai.

keywords:Analytics,Human Resources Hr,Marketing,Marketing Analytics, saas

$99.2M

Total Funding

267

Number of Employees

$40.2M

Revenue (est)

-4%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Aktana News

2021-10-06 - Aktana Launches Next Generation of its Contextual Intelligence Engine to Accelerate Enterprise-Wide AI Adoption

SAN FRANCISCO, Oct. 06, 2021 (GLOBE NEWSWIRE) -- Aktana, the leader in intelligent customer engagement for the global life sciences industry, today announced its Contextual Intelligence Engine (CIE) 2.0. The upgraded version of the CIE is designed specifically for two of the most urgent needs in ...

2021-10-06 - Aktana Launches Contextual Intelligence 360 to Solve the Challenge of Personalizing Customer Engagement at Scale

New Solution Serves as the Intelligence Command Center for Life Sciences Commercial and Medical Teams SAN FRANCISCO, Oct. 06, 2021 (GLOBE NEWSWIRE) -- Aktana, the leader in intelligent customer engagement for the global life sciences industry, today announced Contextual Intelligence 360, a new, ...

2021-10-06 - Aktana Launches Contextual Intelligence 360 to Solve the Challenge of Personalizing Customer Engagement at Scale

SAN FRANCISCO, Oct. 06, 2021 (GLOBE NEWSWIRE) -- Aktana, the leader in intelligent customer engagement for the global life sciences industry, today announced Contextual Intelligence 360, a new, modular solution that enables commercial teams to rapidly scale AI-driven programs that personalize th ...

2019-09-08 - Aktana Co-Founder Named Among 100 Most Inspiring People ...

SAN FRANCISCO--(BUSINESS WIRE)-- Today, Aktana, the pioneer in AI-enabled decision support for global life science companies, ...

2019-09-07 - Aktana Partners with Komodo Health to Drive Greater Healthcare Provider Engagement for Life Sciences Companies

SAN FRANCISCO, May 13, 2019 /PRNewswire/ -- Aktana, a pioneer in AI-enabled decision support for global life science companies, and ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$64.4M267-17%$154.3M
#2
$40.2M2670%$58M
#3
$41.8M26829%$21M
#4
$41.8M268-18%$89M
#5
$15M268N/AN/A

Aktana Funding

DateAmountRoundLead InvestorsReference
2016-06-09$17.5MUndisclosedSafeguard Scientifics IncArticle